• >
  • >
  • >
  • >
  • >
Jin Li
Life Science
Shanghai University
Shanghai
Language: Chinese, English
Contact
Muscle Atrophy Molecular Biology Treatment Development Heart Failure Cardiac Research Muscle Research Molecular Therapy Gene Editing Crispr/Cas9 Mirna
Areas of Focus
  • Molecular mechanisms and treatment methods for muscle atrophy
  • Molecular mechanisms of heart failure
Work Experience
  • 2018 - Present - Shanghai University, School of Life Sciences
Academic Background & Achievements
  • 2012 - Bachelor's Degree: Anhui University
  • 2018 - PhD: Shanghai University
  • Awards include First Prize in Science and Technology from the Chinese Association of Rehabilitation Medicine
Publications
  • Mir-30d Regulates Cardiac Remodeling by Intracellular and Paracrine Signaling, First Author, 2021
  • Targeting miR-30d reverses pathological cardiac hypertrophy, First Author, 2022
  • Inhibition of lncRNA MAAT Controls Multiple Types of Muscle Atrophy by cis- and trans-Regulatory Actions, First Author, 2021
  • CRISPR/Cas9-Mediated miR-29b Editing as a Treatment of Different Types of Muscle Atrophy in Mice, First Author, 2020
  • MiR-29b Contributes to Multiple Types of Muscle Atrophy, First Author, 2017
Awards
  • First Prize in Science and Technology from the Chinese Association of Rehabilitation Medicine
  • First Prize in Rehabilitation Medical Science and Technology Award from Shanghai
  • Third Prize in Zhang Xijun National Young Excellent Physiology Academic Paper from the Chinese Physiological Society
Post a Project

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that AGP may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from AGP.
Submit

Thank you for your message!
We will contact you soon.